IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — BRZE

Balance Sheet

(in billions USD)
MetricQ1 2027Q3 2026Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022
Cash & Equivalents0.150.100.080.230.060.080.070.060.080.120.050.080.090.04
Accounts Receivable0.120.090.090.090.090.070.080.070.070.070.060.050.040.04
Total Current Assets0.550.500.480.660.610.610.600.570.570.600.560.580.600.13
Property, Plant & Equipment0.040.040.040.040.040.040.040.020.020.020.020.020.010.01
Goodwill0.260.270.270.030.030.030.030.030.03----------
Intangible Assets0.060.060.070.000.000.000.000.000.00----------
Total Non-current Assets*0.540.540.540.230.230.220.220.200.160.120.120.120.120.05
Total Assets1.091.041.020.890.840.830.820.770.730.720.680.700.720.18
Accounts Payable0.010.000.000.000.000.000.000.010.000.000.000.000.000.00
Total Current Liabilities0.440.370.350.340.310.300.310.250.250.250.180.180.180.12
Total Non-current Liabilities*0.070.070.070.070.080.070.070.080.040.040.040.040.050.00
Total Liabilities0.510.440.420.410.380.370.380.330.290.290.220.230.230.12
Retained Earnings(0.74)(0.69)(0.65)(0.62)(0.57)(0.54)(0.52)(0.45)(0.42)(0.39)(0.32)(0.29)(0.25)(0.17)
Total Stockholder Equity0.580.600.600.470.460.450.440.440.440.440.450.470.48(0.12)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Total Revenue211.00205.17190.84180.11162.06160.40152.05145.50135.46130.96123.96115.11101.7898.6893.1386.1377.5070.4363.97
Cost of Revenue72.3470.8262.6358.2250.8649.3145.9143.4244.5542.9936.3735.4732.6933.4229.1427.3525.9124.7819.17
Gross Profit138.66134.35128.21121.89111.20111.09106.14102.0890.9187.9787.5879.6369.0965.2563.9958.7851.5945.6644.79
Research & Development46.1045.0344.0741.2536.8033.6032.8533.1434.3731.1129.8729.1329.7526.7525.5823.3421.6222.9012.74
Selling, General & Admin30.8935.8733.0936.7940.5029.7831.2028.3226.7926.0926.4525.4523.9822.2222.4320.5423.5719.6212.94
Total Operating Expenses166.18162.59165.76160.64151.42132.65138.71130.03130.99120.26122.72115.00110.99101.77100.8593.8991.2488.2555.24
Operating Income(27.51)(28.24)(37.54)(38.75)(40.22)(21.56)(32.57)(27.95)(40.08)(32.29)(35.13)(35.37)(41.90)(36.52)(36.86)(35.11)(39.65)(42.59)(10.45)
Pretax Income(24.06)(24.68)(34.14)(34.77)(34.57)(15.97)(27.28)(22.45)(34.91)(27.94)(30.59)(31.50)(38.44)(32.88)(34.28)(33.38)(39.62)(42.23)(10.67)
Tax Provision1.436.901.66(7.01)1.071.090.850.700.800.640.390.550.390.93(0.39)0.040.011.12(1.61)
Net Income(26.59)(31.60)(36.00)(27.90)(35.79)(17.19)(27.91)(23.00)(35.64)(28.28)(30.74)(31.69)(38.45)(33.45)(33.36)(32.89)(39.27)(42.93)(8.72)
Basic EPS(0.24)(0.29)(0.33)(0.26)(0.34)(0.17)(0.27)(0.23)(0.35)(0.28)(0.31)(0.33)(0.40)(0.35)(0.35)(0.35)(0.42)(0.53)(0.42)
Diluted EPS(0.24)(0.29)(0.33)(0.26)(0.34)(0.17)(0.27)(0.23)(0.35)(0.28)(0.31)(0.33)(0.40)(0.35)(0.35)(0.35)(0.42)(0.53)(0.42)

Cash Flow Statement

(in millions USD)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Operating Cash Flow28.1319.3820.976.9524.1417.08(11.41)11.6119.403.82(2.00)(17.52)22.550.01(23.92)(16.32)17.92(24.53)(10.87)
Capital Expenditures0.114.821.942.610.221.091.923.316.926.323.010.390.041.384.227.881.961.201.11
Free Cash Flow*28.0214.5619.024.3423.9316.00(13.33)8.3012.48(2.50)(5.01)(17.90)22.51(1.37)(28.14)(24.20)15.96(25.73)(11.98)
Investing Cash Flow42.80(7.46)(5.73)(160.55)122.84(0.84)(8.20)(16.83)(10.60)(0.50)(15.99)(27.78)24.3018.02(12.74)4.00(407.80)(1.75)19.79
Financing Cash Flow(49.69)13.801.087.480.616.181.485.92(1.88)4.101.675.122.214.121.802.782.63463.314.60

* Derived from reported values